- Home
- VIRT vs KLTOW Comparison
VIRT vs KLTOW Comparison
Compare VIRT & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRT
- KLTOW
- Stock Information
- Founded
- VIRT 2008
- KLTOW N/A
- Country
- VIRT United States
- KLTOW United States
- Employees
- VIRT N/A
- KLTOW 3
- Industry
- VIRT Investment Bankers/Brokers/Service
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VIRT Finance
- KLTOW Health Care
- Exchange
- VIRT Nasdaq
- KLTOW Nasdaq
- Market Cap
- VIRT 3.3B
- KLTOW N/A
- IPO Year
- VIRT 2015
- KLTOW 2022
- Fundamental
- Price
- VIRT $44.51
- KLTOW $0.24
- Analyst Decision
- VIRT Hold
- KLTOW
- Analyst Count
- VIRT 8
- KLTOW 0
- Target Price
- VIRT $37.25
- KLTOW N/A
- AVG Volume (30 Days)
- VIRT 749.5K
- KLTOW N/A
- Earning Date
- VIRT 07-17-2025
- KLTOW N/A
- Dividend Yield
- VIRT 2.16%
- KLTOW N/A
- EPS Growth
- VIRT 142.03
- KLTOW N/A
- EPS
- VIRT 3.46
- KLTOW N/A
- Revenue
- VIRT $2,401,575,000.00
- KLTOW N/A
- Revenue This Year
- VIRT N/A
- KLTOW N/A
- Revenue Next Year
- VIRT N/A
- KLTOW N/A
- P/E Ratio
- VIRT $12.87
- KLTOW N/A
- Revenue Growth
- VIRT 43.16
- KLTOW N/A
- 52 Week Low
- VIRT $21.59
- KLTOW N/A
- 52 Week High
- VIRT $44.96
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- VIRT 64.02
- KLTOW N/A
- Support Level
- VIRT $43.15
- KLTOW N/A
- Resistance Level
- VIRT $44.96
- KLTOW N/A
- Average True Range (ATR)
- VIRT 0.93
- KLTOW 0.00
- MACD
- VIRT 0.19
- KLTOW 0.00
- Stochastic Oscillator
- VIRT 90.36
- KLTOW 0.00
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.